Graça Esteves
About
In The Last Decade
Graça Esteves
10 papers receiving 99 citations
Peers
Comparison fields: 5 of 32
- Hematology 86
- Molecular Biology 82
- Oncology 61
- Surgery 6
- Public Health, Environmental and Occupational Health 6
Countries citing papers authored by Graça Esteves
This map shows the geographic impact of Graça Esteves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graça Esteves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graça Esteves more than expected).
Fields of papers citing papers by Graça Esteves
This network shows the impact of papers produced by Graça Esteves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graça Esteves. The network helps show where Graça Esteves may publish in the future.
Co-authorship network of co-authors of Graça Esteves
This figure shows the co-authorship network connecting the top 25 collaborators of Graça Esteves. A scholar is included among the top collaborators of Graça Esteves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graça Esteves. Graça Esteves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 4 | |
| 8 | 21 | |
| 9 | 58 | |
| 10 | 1 | |
| 11 | 2 | |
| 12 | Phase II study of bortezomib, thalidomide, and dexamethasone /- cyclophosphamide as induction therapy in previously untreated multiple myeloma (MM): safety and activity including evaluation of MRD | 4 |
| 13 | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.